Sleep Disorder, Shift Work (Shift Work Disorder, SWD)
BASICS
- Definition:
- Circadian rhythm sleep-wake disorder, characterized by insomnia and/or excessive sleepiness due to misalignment between internal circadian rhythms and required sleep-wake schedules from nontraditional work shifts (night, evening, early morning, rotating, irregular).
- Systems affected: nervous, cardiovascular, metabolic
EPIDEMIOLOGY
- Prevalence:
- 20% of U.S. employed adults are shift workers (esp. healthcare, transportation, food services, protective services)
- 1 in 3 shift workers experience insomnia or sleep disturbance; ~90% report daytime sleepiness/fatigue
- Estimated SWD prevalence: 2β5% in the general U.S. population
- Risk increases with age (>50 years)
ETIOLOGY & PATHOPHYSIOLOGY
- Pathophysiology:
- Circadian misalignment between endogenous rhythms and nontraditional sleep-wake schedules leads to sleep onset/maintenance insomnia and/or excessive sleepiness during required awake hours
- Genetics:
- Morning/evening preference partially linked to polymorphisms of the PER3 clock gene
RISK FACTORS
- Age >50 years
- Strong social/domestic demands
- Prolonged/irregular shift schedules
PREVENTION
- Reduce or avoid shift work if possible
- Rotate shifts forward (morning β afternoon β night)
- Bright light exposure during shifts
- Consistent sleep schedule, strategic naps before or during shift
- Practice sleep hygiene
COMMONLY ASSOCIATED CONDITIONS
- Impaired recall, decreased processing speed, attention deficits
- Increased risk: vehicular/work accidents, GI disorders, CVD, diabetes, possible cancers
- Higher rates of mood disorders and substance use
DIAGNOSIS
DSM-5 Criteria (Circadian Rhythm Sleep-Wake Disorder)
- Persistent/recurrent sleep disruption due to circadian misalignment (physical/social/professional)
- Leads to excessive sleepiness and/or insomnia
- Causes significant distress/impairment in functioning
Additional SWD Criteria
- Insomnia during sleep period and/or excessive sleepiness during awake period tied to shift work
- Classified as: episodic (1β3 mo), persistent (>3 mo), or recurrent (β₯2 episodes/year)
HISTORY
- Detailed sleep/work history, degree of sleepiness, performance/safety risk
- Evaluate for coexisting sleep disorders (OSA, RLS, narcolepsy)
PHYSICAL EXAM
- Assess for mood disorders, obesity/large neck (OSA risk), CVD, diabetes, GI disease
DIFFERENTIAL DIAGNOSIS
- Primary insomnia, sleep-related breathing disorders, central hypersomnolence, parasomnias, movement disorders
- Other circadian rhythm disorders (delayed sleep phase, irregular sleep-wake)
DIAGNOSTIC TESTS
- Diagnosis is clinical; no routine labs
- Consider polysomnography or multiple sleep latency test if other sleep disorder suspected
- 2-week sleep diary, Insomnia Severity Index (ISI), Epworth Sleepiness Scale (ESS) can aid in assessment
TREATMENT
GENERAL MEASURES
- Sleep hygiene:
- Minimize light before/during sleep (dark room, blackout shades, sunglasses after shift)
- Quiet, cool environment, white noise, ear plugs
- Avoid stimulants during latter half of shift
- Scheduled/protected sleep:
- Anchor sleep (consistent sleep blocks overlapping work/nonwork days)
- Strategic naps (<1 hour) before/during shift (beware post-nap sleep inertia)
- Lifestyle:
- Manage stress/depression, healthy diet, regular exercise (avoid within 2β4h of bedtime), limit substances
- Social support for sleep protection
- Work modifications:
- <4 consecutive shifts, shift duration <12h, >11h between shifts, avoid heavy work during circadian nadir (4β7am)
LIGHT EXPOSURE
- Bright light therapy (>2,000 lux, blue wavelengths) during shift to promote alertness
- Light avoidance after shift to promote daytime sleep
MEDICATION
- Sleep-promoting:
- Melatonin 3 mg (AASM recommended), 30 min before daytime sleep
- Ramelteon (Rozerem), doxepin (low-dose), trazodone (second-line), nonbenzo hypnotics (zolpidem, eszopiclone, suvorexant)βshort-term only
- Wakefulness-promoting:
- Modafinil 200 mg or armodafinil 150 mg 1h before shift (FDA approved for SWD)
- Prophylactic caffeine (first half of shift only)
- Note:
- Long-term use of hypnotics not recommended; risk of dependence and residual sedation
FIRST LINE
- Melatonin 3 mg before daytime sleep
SECOND LINE
- Modafinil/armodafinil before shift, hypnotics before daytime sleep, short-term low-dose antidepressants if needed
REFERRAL
- Sleep specialist for suspected primary sleep disorders, hypnotic/stimulant dependence, or persistent symptoms
ADDITIONAL THERAPIES
- Cognitive-behavioral therapy for insomnia (CBT-I)
- Fatigue risk management programs
ONGOING CARE
- Patient education on sleep hygiene, environment optimization, risk of accidents with sleep loss
- Encourage use of sleep diary
- Symptoms resolve if shift work is eliminated (not always feasible)
ICD-10
- G47.26: Circadian rhythm sleep disorder, shift work type
CLINICAL PEARLS
- SWD β increased risk of metabolic and mood disorders
- First diagnostic step: thorough sleep/work history and 2-week sleep diary
- Shift workers are at highest accident risk during night/early morning shifts